首页|期刊导航|中华医学杂志（英文版）|Leukocyte immunoglobulin-like receptor B4(LILRB4)in acute myeloid leukemia:From prognostic biomarker to immunotherapeutic target

Leukocyte immunoglobulin-like receptor B4(LILRB4)in acute myeloid leukemia:From prognostic biomarker to immunotherapeutic target

Muzi Li Xiangyu Zhao

中华医学杂志（英文版）2024，Vol.137Issue(22)：2697-2711,15.

中华医学杂志（英文版）2024，Vol.137Issue(22)：2697-2711,15.DOI:10.1097/CM9.0000000000003195

Leukocyte immunoglobulin-like receptor B4(LILRB4)in acute myeloid leukemia:From prognostic biomarker to immunotherapeutic target

Muzi Li ¹Xiangyu Zhao¹

作者信息

1. Peking University People's Hospital,Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation,National Clinical Research Center for Hematologic Disease,Beijing 100044,China
折叠

摘要

关键词

LILRB4/Leukemia,myeloid,acute/Immune checkpoint/Tumor microenvironment/Immunotherapy

Key words

LILRB4/Leukemia,myeloid,acute/Immune checkpoint/Tumor microenvironment/Immunotherapy

引用本文复制引用

Muzi Li,Xiangyu Zhao..Leukocyte immunoglobulin-like receptor B4(LILRB4)in acute myeloid leukemia:From prognostic biomarker to immunotherapeutic target[J].中华医学杂志（英文版）,2024,137(22):2697-2711,15.

基金项目

This study was supported by grants from National Natural Science Foundation of China(Nos.82350105,82270228,and 82070184),Science,Technology & Innovation Pro-ject of Xiongan New area(No.2023XACX0004),Beijing Nova Program(No.20220484235),Clinical Medicine Plus X-Young Scholars Project of Peking University,the Fundamental Research Funds for the Central Universities,Peking University People's Hospital Research and Devel-opment Funds(No.RDL2021-01),. （Nos.82350105,82270228,and 82070184）

中华医学杂志（英文版）

OACSTPCDMEDLINE

ISSN：0366-6999

访问量0

下载量0

段落导航